GlassScriptPhysician profile
Julia A Lindower
NPI 1629395793
$12,160.49
in general payments reported to CMS, 2019-2025
46 companies · $3,209 in 2025
The $3,209 reported for 2025 was more than what 97% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $674 · 2022: $1,622 · 2023: $2,222 · 2024: $4,433 · 2025: $3,209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,506 · Travel and Lodging: $1,326 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,506.23 |
| Travel and Lodging | $1,325.67 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,952.20 | 2023-2025 | Minimed 780g |
| Lilly USA, LLC | $1,457.96 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $1,105.01 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $822.40 | 2022-2025 | Evenity, Repatha, Repatha |
| Dexcom, INC. | $700.19 | 2023-2025 | Dexcom G6 Transmitter, Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor |
| Bayer Healthcare Pharmaceuticals INC. | $663.23 | 2022-2025 | |
| Mannkind Corporation | $627.49 | 2023-2025 | Afrezza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $531.49 | 2021-2025 | Jardiance, Tradjenta, Synjardy |
| Sanofi-Aventis U.S. LLC | $516.76 | 2022-2025 | |
| Beta Bionics, INC. | $482.37 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Corcept Therapeutics | $357.99 | 2021-2025 | Korlym |
| Abbott Laboratories | $345.87 | 2022-2025 | Freestyle Libre 3, Eterna |
| Sequel Med Tech, LLC | $267.90 | 2025 | Twiist |
| Antares Pharma, INC. | $219.83 | 2022-2025 | Xyosted |
| Tandem Diabetes Care, INC. | $216.32 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Lindower listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.